Patent application number | Description | Published |
20090005551 | SYNTHESIS OF 5-AZACYTIDINE - The present invention provides a method for the preparation of 5-azacytidine, wherein 5-azacytidine is represented by the structure: | 01-01-2009 |
20100247659 | PHENYLPHTHALIMIDE ANALOGS FOR TREATING DIABETIC MACULAR EDEMA - Novel methods are provided to prevent blindness associated with diabetic macular edema by administration of a phenylphthalimide analog. Additionally, sustainability of the effect of administration of the phenylphthalimide analog is improved via encapsulation with poly(lactic-co-glycolic acid) nanoparticles. Finally, a novel method for synthesizing (2,6-diisopropylphenyl)-5-amino-1H-isoindole-1,3-dione is disclosed. | 09-30-2010 |
20100292180 | Pharmaceutical Compositions Comprising Crystal Forms of 5-Azacytidine - The invention includes methods for isolating crystalline Form I of 5-azacytidine substantially free of other forms, wherein 5-azacytidine is represented by the formula: | 11-18-2010 |
20100298253 | Pharmaceutical Compositions Comprising Forms of 5-Azacytidine - The invention provides novel polymorphic and pseudopolymorphic crystalline forms of 5-azacytidine, along with methods for preparing said forms, wherein 5-azacytidine is represented by the formula: | 11-25-2010 |
20110092694 | SYNTHESIS OF 5-AZACYTIDINE - The present invention provides a method for the preparation of 5-azacytidine, wherein 5-azacytidine is represented by the structure: | 04-21-2011 |
20120029181 | SYNTHESIS OF 5-AZACYTIDINE - The present invention provides a method for the preparation of 5-azacytidine, wherein 5-azacytidine is represented by the structure: | 02-02-2012 |
20120245342 | METHODS FOR ISOLATING CRYSTALLINE FORM I OF 5-AZACYTIDINE - The invention includes methods for isolating crystalline Form I of 5-azacytidine substantially free of other forms, wherein 5-azacytidine is represented by the formula: | 09-27-2012 |
20130059809 | PHARMACEUTICAL COMPOSITIONS COMPRISING FORMS OF 5-AZACYTIDINE - The invention provides novel polymorphic and pseudopolymorphic crystalline forms of 5-azacytidine, along with methods for preparing said forms, wherein 5-azacytidine is represented by the formula: | 03-07-2013 |
20130059810 | PHARMACEUTICAL COMPOSITIONS COMPRISING FORMS OF 5-AZACYTIDINE - The invention provides novel polymorphic and pseudopolymorphic crystalline forms of 5-azacytidine, along with methods for preparing said forms, wherein 5-azacytidine is represented by the formula: | 03-07-2013 |
20130274459 | METHODS FOR ISOLATING CRYSTALLINE FORM I OF 5-AZACYTIDINE - The invention includes methods for isolating crystalline Form I of 5-azacytidine substantially free of other forms, wherein 5-azacytidine is represented by the formula: | 10-17-2013 |
20140107058 | PHARMACEUTICAL COMPOSITIONS COMPRISING FORMS OF 5-AZACYTIDINE - The invention provides novel polymorphic and pseudopolymorphic crystalline forms of 5-azacyditine, along with methods for preparing said forms, wherein 5-azacytidine is represented by the formula: | 04-17-2014 |